[1] [1] MAO Y, REN J, YANG L F. Advances of nanomedicine in treatment of atherosclerosis and thrombosis[J]. Environ Res, 2023, 238(Pt 2): 116637.

[2] [2] FREUND Y, ROUSSEAU A, GUYOT-ROUSSEAU F, et al. PERC rule to exclude the diagnosis of pulmonary embolism in emergency low-risk patients: study protocol for the PROPER randomized controlled study[J]. Trials, 2015, 16(1): 537.

[4] [4] GHASEMI M, OH J, JEONG S, et al. Fabry-perot interferometric fiber-optic sensor for rapid and accurate thrombus detection[J]. Biosensors, 2023, 13(8): 817.

[5] [5] QIAO R R, HUANG X M, QIN Y, et al. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis[J]. Nanoscale, 2020, 12(15): 8040-8064.

[6] [6] LUPPA P B, MLLER C, SCHLICHTIGER A, et al. Point-of-care testing (POCT): current techniques and future perspectives[J]. Trac Trends Anal Chem, 2011, 30(6): 887-898.

[7] [7] BULLER H R, CATE-HOEK A J, HOSE A W. et al. Safely ruling out deep venous thrombosis in primary care[J]. Ann Intern Med, 2009, 150(4): 229-35.

[8] [8] PRICE C P, FAY M, HOPSTAKEN R M. Point-of-care testing for D-dimer in the diagnosis of venous thromboembolism in primary care: a narrative review[J]. Cardiol Ther, 2021, 10(1): 27-40.

[9] [9] TEN CATE-HOEK A J, TOLL D B, BLLER H R, et al. Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual[J]. J Thromb Haemost, 2009, 7(12): 2042-2049.

[10] [10] GROSSE S D, NELSON R E, NYARKO K A, et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs[J]. Thromb Res, 2016, 137: 3-10.

[11] [11] ZHOU J R, QI Q Q, WANG C, et al. Surface plasmon resonance (SPR) biosensors for food allergen detection in food matrices[J]. Biosens Bioelectron, 2019, 142: 111449.

[12] [12] HU X E, LV D Y, QI M Y, et al. A new surface plasmon resonance-based immunoassay for rapid and sensitive quantification of D-dimer in human plasma for thrombus screening[J]. J Chromatogr B, 2024, 1238: 124102.

[13] [13] MOBERG A, LAGER A, HMLINEN M D, et al. Increased sensitivity of SPR assays in plasma through efficient parallel assay optimization[J]. J Pharm Biomed Anal, 2013, 78: 224-232.

[14] [14] BHAT M, ABUZIED Y, FAGIH Z, et al. Efficacy of point-of-care for INR testing compared to standard laboratory methods at a tertiary care hospital in Saudi Arabia[J]. Glob J Qual Saf Healthc, 2020, 3(3): 98-104.

[15] [15] LAURENCE C O, GIALAMAS A, BUBNER T, et al. Patient satisfaction with point-of-care testing in general practice[J]. Br J Gen Pract, 2010, 60(572): e98-104.

[16] [16] ARAJO A C O, DOMINGUES R B, VAN BELLEN B. Comparison between the conventional method and a portable device for determination of INR[J]. J Vasc Bras, 2014, 13(2): 88-93.

[17] [17] LEITO C, PEREIRA S O, MARQUES C, et al. Cost-effective fiber optic solutions for biosensing[J]. Biosensors, 2022, 12(8): 575.

[18] [18] DZIUDA . Fiber-optic sensors for monitoring patient physiological parameters: a review of applicable technologies and relevance to use during magnetic resonance imaging procedures[J]. J Biomed Opt, 2015, 20(1): 010901.

[19] [19] NEDOMA J, KEPAK S, FAJKUS M, et al. Magnetic resonance imaging compatible non-invasive fibre-optic sensors based on the Bragg gratings and interferometers in the application of monitoring heart and respiration rate of the human body: a comparative study[J]. Sensors, 2018, 18(11): 3713.

[20] [20] Ultrasound guidelines: emergency, point-of-care, and clinical ultrasound guidelines in medicine[J]. Ann Emerg Med, 2023, 82(3): e115-e155.

[21] [21] POMERO F, DENTALI F, BORRETTA V, et al. Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis[J]. Thromb Haemost, 2013, 109(1): 137-145.

[22] [22] ZHANG P, QU Y L, TU J, et al. Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin[J]. J Clin Ultrasound, 2020, 48(9): 522-526.

[23] [23] ALHARTHY A, FAQIHI F, ABUHAMDAH M, et al. Prospective longitudinal evaluation of point-of-care lung ultrasound in critically ill patients with severe COVID-19 pneumonia[J]. J Ultrasound Med, 2021, 40(3): 443-456.

[24] [24] ESTRELLA Y, BRONZO A, FEY L, et al. Point-of-care ultrasound: impact on emergency department length of stay for suspected lower extremity DVT[J]. Emerg Radiol, 2023, 30(2): 203-207.

[25] [25] ADHIKARI S, ZEGER W, THOM C, et al. Isolated deep venous thrombosis: implications for 2-point compression ultrasonography of the lower extremity[J]. Ann Emerg Med, 2015, 66(3): 262-266.

[26] [26] CANAKCI M E, ACAR N, BILGIN M, et al. Diagnostic value of point-of-care ultrasound in deep vein thrombosis in the emergency department[J]. J Clin Ultrasound, 2020, 48(9): 527-531.

[27] [27] LEE J H, LEE S H, YUN S J. Comparison of 2-point and 3-point point-of-care ultrasound techniques for deep vein thrombosis at the emergency department: a metaanalysis[J]. Medicine (Baltimore), 2019, 98(22): e15791.

[28] [28] FRANKEL H L, KIRKPATRICK A W, ELBARBARY M, et al. Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients: part I[J]. Crit Care Med, 2015, 43(11): 2479-2502.

[29] [29] BLAIVAS M, LAMBERT M J, HARWOOD R A, et al. Lower-extremity Doppler for deep venous thrombosis: can emergency physicians be accurate and fast?[J]. Acad Emerg Med, 2000, 7(2): 120-126.

[30] [30] GRAY B P, KELLY L, STEEN-BURRELL K A, et al. Rapid molecular imaging of active thrombiin vivousing aptamer-antidote probes[J]. Mol Ther Nucleic Acids, 2023, 31: 440-451.

[31] [31] NIMJEE S M, WHITE R R, BECKER R C, et al. Aptamers as therapeutics[J]. Annu Rev Pharmacol Toxicol, 2017, 57: 61-79.

[32] [32] ZHANG W, LI M M, WANG X, et al. Precision navigation of venous thrombosis guided by viscosity-activatable near-infrared fluorescence[J]. Anal Chem, 2023, 95(4): 2382-2389.

[33] [33] DYR J E, STIKAROVA J, SUTTNAR J, et al. Measurable amount of active thrombin is bound to circulating D-dimers. is there any impact on diagnosis and pathophysiology of thrombosis?[J]. Blood, 2016, 128(22): 2570.

[34] [34] ALONS I M E, JELLEMA K, WERMER M J H, et al. D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache[J]. BMC Neurol, 2015, 15(1): 118.

[35] [35] GOTTLIEB I, PINHEIRO A, BRINKER J A, et al. Diagnostic accuracy of arterial phase 64-slice multidetector CT angiography for left atrial appendage thrombus in patients undergoing atrial fibrillation ablation[J]. J Cardiovasc Electrophys, 2008, 19(3): 247-251.

[36] [36] MARTINEZ M W, KIRSCH J, WILLIAMSON E E, et al. Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation[J]. JACC Cardiovasc Imag, 2009, 2(1): 69-76.

[37] [37] GOROG D A, BECKER R C. Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement[J]. J Thromb Thrombolysis, 2021, 51(1): 1-11.